Company Financials

Pulse Biosciences, Inc. Financials

United States dollar

business Pulse Biosciences, Inc. Company Profile

Main Stock Listing

NASDAQ: PLSE

Market Capitalization $907.4 Million as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -14.55
Forward PE -14.88
Price to Sales TTM $10551.25
Price to Book MRQ $9.79
Enterprise to Revenue 9535.86
Enterprise to EBITDA -10.53

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 0.00%
Operating Margin -23682.56%
Return on Assets TTM -48.90%
Return on Equity TTM -86.99%

Income Statement

Revenue TTM $86,000
Revenue per Share TTM $0.00
Quarterly Revenue Growth %
Gross Profit TTM $-193,000
EBITDA $-77,848,000
Net Income to Common TTM $-74,733,000
Diluted EPS TTM $-1.14
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ $95,214,000
Total Cash per Share MRQ $1.41
Total Debt MRQ $
Total Debt to Equity MRQ 8.51
Current Ratio MRQ 10.02
Book Value per Share MRQ $1.37

Cash Flow

Operating Cash Flow TTM $-48,511,000
Levered Free Cash Flow TTM $-23,174,876

PLSE Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 67,738,000
Float Shares 17,572,133
Avg 10 Volume 173,600
Avg 30 Volume None
Shares Short 2,592,843
Short Ratio 14.07
Short % of Shares 14.59%
% Held by Insiders 73.94%
% Held by Institutions 8.92%

Stock Price Summary

Beta 1.81
Fifty Two Week Low $12.56
Fifty Two Week High $25.00
Fifty Two Week Change -43.02%
Day 50 MA $14.79
Day 200 MA $16.00

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date